| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51dd24b692ace975be34b3f6d3719823 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2013-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32bbbaaeedf7d71ae0df1cfab2649674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e216e45fe44f2dcdc8672e33635a243f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d182c60c8cf2272a66ad1248c5c9a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c531dc17d8691fc7d0f93d56996389ad |
| publicationDate |
2014-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014034735-A1 |
| titleOfInvention |
Dna vaccine containing vegf-specific epitope and/or angiopoietin-2-specific epitope |
| abstract |
The present invention provides a therapeutic or prophylactic agent for cancer, which contains an expression vector encoding a chimeric hepatitis B virus core antigen polypeptide into which an amino acid sequence containing a VEGF-specific epitope and/or an angiopoietin-2-specific epitope is inserted, wherein the amino acid sequence containing the specific epitope is inserted between an amino acid residue located at position-80 and an amino acid residue located at position-81 in a hepatitis B virus core antigen polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016080540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022071513-A1 |
| priorityDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |